Cargando…

Characteristics of intermediate age-related macular degeneration with hyperreflective foci

Hyperreflective foci (HRF) are the findings observed in optical coherence tomography (OCT) in several retinal diseases and are believed to be associated with the increased risk of atrophy in eyes with age-related macular degeneration (AMD). In this study, we investigated the clinical and genetic cha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kikushima, Wataru, Sakurada, Yoichi, Sugiyama, Atsushi, Yoneyama, Seigo, Matsubara, Mio, Fukuda, Yoshiko, Shijo, Taiyo, Kotoda, Yumi, Fragiotta, Serena, Kashiwagi, Kenji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626558/ https://www.ncbi.nlm.nih.gov/pubmed/36319691 http://dx.doi.org/10.1038/s41598-022-23380-w

Ejemplares similares

Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration
por: Shijo, Taiyo, et al.
Publicado: (2020)

A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result
por: Kikushima, Wataru, et al.
Publicado: (2023)

Five-Year Outcome of Aflibercept Monotherapy for Exudative Age-Related Macular Degeneration with Good Baseline Visual Acuity
por: Kikushima, Wataru, et al.
Publicado: (2021)

Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degeneration
por: Fukuda, Yoshiko, et al.
Publicado: (2019)

Distinct characteristics of central serous chorioretinopathy according to gender
por: Yoneyama, Seigo, et al.
Publicado: (2022)

Genetic factors associated with response to as-needed aflibercept therapy for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
por: Yoneyama, Seigo, et al.
Publicado: (2020)

Correction: Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy
por: Kikushima, Wataru, et al.
Publicado: (2020)

Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy
por: Wataru, Kikushima, et al.
Publicado: (2020)

Pachydrusen in Fellow Eyes Predict Response to Aflibercept Monotherapy in Patients with Polypoidal Choroidal Vasculopathy
por: Fukuda, Yoshiko, et al.
Publicado: (2020)

Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular Edema
por: Kikushima, Wataru, et al.
Publicado: (2021)

Incidence and risk of advanced age-related macular degeneration in eyes with drusenoid pigment epithelial detachment
por: Shijo, Taiyo, et al.
Publicado: (2022)

Comparison of Outcomes between 3 Monthly Brolucizumab and Aflibercept Injections for Polypoidal Choroidal Vasculopathy
por: Fukuda, Yoshiko, et al.
Publicado: (2021)

Significance of Hyperreflective Foci as an Optical Coherence Tomography Biomarker in Retinal Diseases: Characterization and Clinical Implications
por: Fragiotta, Serena, et al.
Publicado: (2021)

Drusenoid Pigment Epithelial Detachment: Genetic and Clinical Characteristics
por: Shijo, Taiyo, et al.
Publicado: (2021)

Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathy
por: Kikushima, Wataru, et al.
Publicado: (2017)

Incidence and risk factors of retreatment after three-monthly aflibercept therapy for exudative age-related macular degeneration
por: Kikushima, Wataru, et al.
Publicado: (2017)

Prevalence and Genetic Characteristics of Geographic Atrophy among Elderly Japanese with Age-Related Macular Degeneration
por: Sakurada, Yoichi, et al.
Publicado: (2016)

Correlation between hyperreflective foci and visual function testing in eyes with intermediate age-related macular degeneration
por: Liu, T. Y. Alvin, et al.
Publicado: (2023)

The combination therapy of subtenon triamcinolone acetonide injection and intravitreal brolucizumab for brolucizumab-related intraocular inflammation
por: Shigemoto, Yumi, et al.
Publicado: (2021)

Response to photodynamic therapy combined with intravitreal aflibercept for polypoidal choroidal vasculopathy depending on fellow-eye condition:2-year results
por: Matsubara, Mio, et al.
Publicado: (2020)

Retinal hyperreflective foci in Fabry disease
por: Atiskova, Yevgeniya, et al.
Publicado: (2019)

Cuticular drusen presenting with central serous chorioretinopathy in both eyes: A case report
por: Hosoda, Shuhei, et al.
Publicado: (2022)

Commentary: Hyperreflective foci on optical coherence tomography and their clinical implications in diabetic macular edema
por: Deb, Amit K, et al.
Publicado: (2021)

Characteristics of Grape Shelf Eye Injuries at Vineyards in Japan
por: Kikushima, Wataru, et al.
Publicado: (2022)

Validation of choroidal hyperreflective foci in diabetic macular edema through a retrospective pilot study
por: Saurabh, Kumar, et al.
Publicado: (2021)

RETINAL HYPERREFLECTIVE FOCI IN TYPE 1 DIABETES MELLITUS
por: Schreur, Vivian, et al.
Publicado: (2020)

Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a COVID-19 patient: A case report
por: Kogure, Chio, et al.
Publicado: (2021)

Hyperreflective Foci in the Outer Retinal Layers as a Predictor of the Functional Efficacy of Ranibizumab for Diabetic Macular Edema
por: Yoshitake, Tatsuya, et al.
Publicado: (2020)

Retinal Hyperreflecting Foci Associate With Cortical Pathology in Multiple Sclerosis
por: Pengo, Marta, et al.
Publicado: (2022)

Hyperreflective foci on optical coherence tomography associate with treatment outcome for anti-VEGF in patients with diabetic macular edema
por: Schreur, Vivian, et al.
Publicado: (2018)

Hyperreflective Foci and Subretinal Fluid Are Potential Imaging Biomarkers to Evaluate Anti-VEGF Effect in Diabetic Macular Edema
por: Qin, Shiyue, et al.
Publicado: (2021)

Automated evaluation of retinal hyperreflective foci changes in diabetic macular edema patients before and after intravitreal injection
por: Wang, Xingguo, et al.
Publicado: (2023)

Hyperreflective Stress Lines and Macular Holes
por: Scharf, Jackson M., et al.
Publicado: (2020)

Decorrelation Signal of Diabetic Hyperreflective Foci on Optical Coherence Tomography Angiography
por: Murakami, Tomoaki, et al.
Publicado: (2018)

Behavior of hyperreflective foci in non-infectious uveitic macular edema, a 12-month follow-up prospective study
por: Berasategui, Barbara, et al.
Publicado: (2018)

Hyperreflective foci in OCT image as a biomarker of poor prognosis in diabetic macular edema patients treating with Conbercept in China
por: Liu, Shulin, et al.
Publicado: (2019)

Choroidal Hyperreflective Foci: A Novel Spectral Domain Optical Coherence Tomography Biomarker in Eyes With Diabetic Macular Edema
por: Roy, Rupak, et al.
Publicado: (2019)

Hyperreflective foci in predicting the treatment outcomes of diabetic macular oedema after anti-vascular endothelial growth factor therapy
por: Huang, Chu-Hsuan, et al.
Publicado: (2021)

Hyperreflective foci as biomarkers for inflammation in diabetic macular edema: Retrospective analysis of treatment naïve eyes from south India
por: Arthi, M, et al.
Publicado: (2021)

Comparison of hyperreflective foci in macular edema secondary to multiple etiologies with spectral-domain optical coherence tomography: An observational study
por: Zhu, Ruilin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0lh4lch7221nqjl4ouau3na4vl